Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ)

CNY 13.18

(1.07%)

Market Cap (In CNY)

11.34 Billion

Revenue (In CNY)

3.95 Billion

Net Income (In CNY)

618.89 Million

Avg. Volume

15.52 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
8.28-13.99
PE
14.56
EPS
0.84
Beta Value
0.146
ISIN
CNE000001K73
CUSIP
-
CIK
-
Shares
861029000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Jin Zhiping
Employee Count
-
Website
https://www.jingxinpharm.com
Ipo Date
2004-07-15
Details
Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. The company offers APIs, antihypertensive products, antibiotics, quinolones, gastrointestinal promotions, antidiabetics, antipileptics, antihistamines, H+ pump depressants, antihyper cholesterolemia products, histamine H2 receptor blokades, antihyper cholesterolemirs, antidepressants, cephalosporin products, and biopharma products. It also provides diagnostic medical displays, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, ultrasonic medical displays, and other products. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1974 and is headquartered in Xinchang, China.